drugset / Trial / NCT00864344

A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Fasting Conditions

NCT00864344

Phase 1 Completed 30 enrolled Actavis Inc.
RandomizedCrossoverOpen-label

Summary

To compare the rate of absorption and oral bioavailability of a test formulation of Sertraline 100 mg tablets manufactured by Purepac Pharmaceutical Company to an equivalent oral dose of the commercially available reference product, Zoloft® manufactured by Pfizer Inc. administrated to healthy subjects after a 10-ghour overnight fast

Timeline

Start
2004-08
Primary completion
2004-08
Completion
2004-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule 100 mg Oral

Indications

No indication recorded.